Dogwood Therapeutics (DWTX) Earnings Date & Reports
Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
DWTX is expected to report earnings to rise 33.33% to -20 cents per share on August 19
Q2'26
Est.
$-0.20
Q1'26
Beat
by $0.47
Q4'25
Missed
by $0.20
Q3'25
Missed
by $8.15
Q2'25
Missed
by $1.94
The last earnings report on May 14 showed earnings per share of -15 cents, beating the estimate of -62 cents. With 374.00 shares outstanding, the current market capitalization sits at 51.77M.